🇺🇸 FDA

Intelligence · Clinical Pipeline

Teva Pharma Pipeline

All ClinicalTrials.gov programs at Teva Pharma — phase, modality, and trial IDs.

Programs
154

Quick answer

Teva Pharma has 154 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. 45-mg hydrocodone bitartrate extended-release tablet (crushed or intact)

    Teva Pharma GmbH

    Drug Abuse

    phase 1 small molecule completed

    1 trial

  2. 5 mg/500 mg Glipizide Metformin Hydrochloride Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  3. 5 mg/500 mg METAGLIP™ Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  4. 600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  5. 90 mg dose of the hydrocodone bitartrate extended-release tablet administered as either two 45-mg tablets (Treatment A) or one 90-mg tablet (Treatment B).

    Teva Pharma GmbH

    Pain

    phase 1 small molecule completed

    1 trial

  6. A randomized, Phase 1b, single-center, observer-blind, active-controlled study to evaluate the safety, immunogenicity, and immunological mechanisms of one single administration of TETRALITE influenza vaccine at two dose levels of LiteVax Adjuvant, in healthy participants aged 60 years and older and in healthy participants aged 18 to 50 years.

    Teva Pharma GmbH

    Influenza

    phase 1 other active

    1 trial

  7. A randomized, Phase I, single-center, observer-blind, active-controlled study to evaluate the safety, tolerability and immunogenicity of one single administration of PCV-LITE, a novel adjuvanted pneumococcal conjugate vaccine at one dose level of LiteVax Adjuvant, in healthy participants aged 18-50 years.

    Teva Pharma GmbH

    Pneumococcal infection

    phase 1 other active

    1 trial

  8. ADASUVE®

    Teva Pharma GmbH

    BiPolar

    phase 1 small molecule completed

    1 trial

  9. ARAVA® 20 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  10. Adapalene

    Teva Pharma GmbH

    Acne Vulgaris

    phase 1 small molecule completed

    1 trial

  11. Albuterol dry powder inhaler

    Teva Pharma GmbH

    Asthma

    phase 1 small molecule completed

    1 trial

  12. Alendronate Sodium Tablets 70mg

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  13. Alprazolam Extended-Release 3 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  14. Amlodipine Besylate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  15. Amlodipine-benazepril 10 mg-20 mg capsules

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  16. Anastrozole

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  17. Anastrozole (Teva Pharmaceuticals USA)

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  18. Arsenic trioxide

    Teva Pharma GmbH

    Chronic Myelogenous Leukemia

    phase 1 small molecule terminated

    1 trial

  19. Azithromycin

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  20. Azithromycin 600 mg Tablet

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  21. BDP HFA Nasal Aerosol

    Teva Pharma GmbH

    Allergic Rhinitis

    phase 1 small molecule completed

    1 trial

  22. BUSPAR® 30 mg Tablet

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  23. Beclomethasone dipropionate BAI

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  24. Benazepril HCl 40 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  25. Bicalutamide

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  26. Buprenorphine

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  27. Bupropion HCl

    Teva Pharma GmbH

    Depressive Disorder

    phase 1 small molecule terminated

    1 trial

  28. CD56-Enriched Donor Lymphocyte Infusion

    Teva Pharma GmbH

    Multiple Myeloma

    phase 1 mab completed

    1 trial

  29. CEP-11981 (kinase inhibitor)

    Teva Pharma GmbH

    Cancer

    phase 1 small molecule completed

    1 trial

  30. CEP-26401

    Teva Pharma GmbH

    Cognitive Impairment

    phase 1 small molecule completed

    1 trial

  31. CEP-37250/KHK2804

    Teva Pharma GmbH

    Solid Tumour

    phase 1 small molecule completed

    1 trial

  32. CEP-37251

    Teva Pharma GmbH

    Bone Loss

    phase 1 small molecule terminated

    1 trial

  33. CEP-37440

    Teva Pharma GmbH

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  34. CEP-9722

    Teva Pharma GmbH

    Solid Tumors or Mantle Cell Lymphoma

    phase 1 small molecule completed

    1 trial

  35. CEP-9722

    Teva Pharma GmbH

    Solid Tumor

    phase 1 small molecule completed

    1 trial

  36. Carvedilol 25 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  37. Cefadroxil 500 mg Capsules

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  38. Cefdinir Capsules 300 mg

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  39. Cefdinir for oral suspension 250 mg/5mL

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  40. Cefprozil for oral suspension 250 mg/5 mL

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  41. Cefzil® 500 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  42. Cilostazol 100 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  43. Cilostazol 50 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  44. Clarithromycin

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  45. Clarithromycin ER 500 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  46. Clindamycin 300 mg capsule

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  47. Custirsen

    Teva Pharma GmbH

    Cardiac Conduction and Repolarization

    phase 1 small molecule completed

    1 trial

  48. Custirsen, paclitaxel and carboplatin

    Teva Pharma GmbH

    Cancer

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Teva Pharma have?

154 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.